Sandoz Gmbh, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding US DMF Number 4789.
Remarkably, this DMF maintains an Active status since its submission on January 06, 1983, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 15, 2013, and payment made on December 21, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II